Extracellular matrix degradation in liver fibrosis: Biochemistry and regulation

被引:206
作者
Iredale, John P. [1 ]
Thompson, Alexandra [1 ]
Henderson, Neil C. [1 ]
机构
[1] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh, Midlothian, Scotland
来源
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE | 2013年 / 1832卷 / 07期
基金
英国惠康基金; 英国医学研究理事会;
关键词
Fibrosis; Matrix; Metalloproteinase; Macrophage; Hepatic stellate cell; HEPATIC STELLATE CELLS; NORMAL RAT-LIVER; FAT-STORING CELLS; TISSUE INHIBITOR; MESENCHYMAL TRANSITION; LIPOCYTES SYNTHESIZE; COLLAGENASE ACTIVITY; TRANSGENIC MOUSE; GENE-EXPRESSION; PRIMARY CULTURE;
D O I
10.1016/j.bbadis.2012.11.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fibrosis is a highly conserved wound healing response and represents the final common pathway of virtually all chronic inflammatory injuries. Over the past 3 decades detailed analysis of hepatic extracellular matrix synthesis and degradation using approaches incorporating human disease, experimental animal models and cell culture have highlighted the extraordinarily dynamic nature of tissue repair and remodelling in this solid organ. Furthermore emerging studies of fibrosis in other organs demonstrate that basic common mechanisms exist, suggesting that bidirectionality of the fibrotic process may not solely be the preserve of the liver. In this review we will examine the cellular and molecular mechanisms that govern extracellular matrix degradation and fibrosis resolution, and highlight how manipulation of these processes may result in the development of effective anti-fibrotic therapies. This article is part of a Special Issue entitled: Fibrosis: Translation of basic research to human disease. (C) 2012 Elsevier B.V. All rights reserved.
引用
收藏
页码:876 / 883
页数:8
相关论文
共 84 条
[81]   Cellular and molecular mechanisms of fibrosis [J].
Wynn, T. A. .
JOURNAL OF PATHOLOGY, 2008, 214 (02) :199-210
[82]   Tissue inhibitor of metalloproteinases-1 promotes liver fibrosis development in a transgenic mouse model [J].
Yoshiji, H ;
Kuriyama, S ;
Miyamoto, Y ;
Thorgeirsson, UP ;
Gomez, DE ;
Kawata, M ;
Yoshii, J ;
Ikenaka, Y ;
Noguchi, R ;
Tsujinoue, H ;
Nakatani, T ;
Thorgeirsson, SS ;
Fukui, H .
HEPATOLOGY, 2000, 32 (06) :1248-1254
[83]   Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the Transgenic mouse [J].
Yoshiji, H ;
Kuriyama, S ;
Yoshii, J ;
Ikenaka, Y ;
Noguchi, R ;
Nakatani, T ;
Tsujinoue, H ;
Yanase, K ;
Namisaki, T ;
Imazu, H ;
Fukui, H .
HEPATOLOGY, 2002, 36 (04) :850-860
[84]   Fibrosis-dependent mechanisms of hepatocarcinogenesis [J].
Zhang, David Y. ;
Friedman, Scott L. .
HEPATOLOGY, 2012, 56 (02) :769-775